Terranova, C., Salutari, V., Plotti, F., Raspagliesi, F., Ricci, C., Donato, V. D., Scollo, P., Giudice, E., Distefano, M. G., Gupta, S., Rao, J. S., Angioli, R., Scambia, G. (2025). Long-term survival analysis of a randomized phase II study of front-line chemo-immunotherapy with carboplatin-paclitaxel using oregovomab indirect immunization in advanced ovarian cancer (QPT-ORE-002).. Journal of Clinical Oncology. https://doi.org/10.1200/jco.2025.43.16_suppl.e17592